XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Shareholders' Equity at Dec. 31, 2018 $ 23,651,277 $ 106,616,083 $ (352,426) $ (126,803,647) $ 3,111,287
Shareholders' Equity (in shares) at Dec. 31, 2018 1,580,693,413        
Stock-based compensation   394,439     394,439
Issuance of share capital related to financing, net of issuance costs $ 65,598 86,955     152,553
Issuance of share capital related to financing, net of issuance costs (in shares) 5,000,000        
Comprehensive loss     107,168 (2,545,283) (2,438,115)
Shareholders' Equity at Mar. 31, 2019 $ 23,716,875 107,097,477 (245,258) (129,348,930) 1,220,164
Shareholders' Equity (in shares) at Mar. 31, 2019 1,585,693,413        
Shareholders' Equity at Dec. 31, 2018 $ 23,651,277 106,616,083 (352,426) (126,803,647) 3,111,287
Shareholders' Equity (in shares) at Dec. 31, 2018 1,580,693,413        
Comprehensive loss         (6,715,315)
Shareholders' Equity at Jun. 30, 2019 $ 24,538,137 107,960,836 (405,374) (133,466,014) (1,372,415)
Shareholders' Equity (in shares) at Jun. 30, 2019 1,650,693,413        
Shareholders' Equity at Mar. 31, 2019 $ 23,716,875 107,097,477 (245,258) (129,348,930) 1,220,164
Shareholders' Equity (in shares) at Mar. 31, 2019 1,585,693,413        
Stock-based compensation   409,622     409,622
Issuance of share capital related to financing, net of issuance costs $ 821,262 453,737     1,274,999
Issuance of share capital related to financing, net of issuance costs (in shares) 65,000,000        
Comprehensive loss     (160,116) (4,117,084) (4,277,200)
Shareholders' Equity at Jun. 30, 2019 $ 24,538,137 107,960,836 (405,374) (133,466,014) (1,372,415)
Shareholders' Equity (in shares) at Jun. 30, 2019 1,650,693,413        
Shareholders' Equity at Dec. 31, 2019 $ 31,987,016 110,498,824 (348,860) (143,909,438) (1,772,458)
Shareholders' Equity (in shares) at Dec. 31, 2019 2,245,865,913        
Stock-based compensation   100,504     100,504
Issuance of share capital related to financing, net of issuance costs $ 8,098,632 (1,003,264)     7,095,368
Issuance of share capital related to financing, net of issuance costs (in shares) 627,029,600        
Comprehensive loss     (222,725) (3,385,062) (3,607,787)
Shareholders' Equity at Mar. 31, 2020 $ 40,085,648 109,596,064 (571,585) (147,294,500) 1,815,627
Shareholders' Equity (in shares) at Mar. 31, 2020 2,872,895,513        
Shareholders' Equity at Dec. 31, 2019 $ 31,987,016 110,498,824 (348,860) (143,909,438) (1,772,458)
Shareholders' Equity (in shares) at Dec. 31, 2019 2,245,865,913        
Comprehensive loss         (11,970,479)
Shareholders' Equity at Jun. 30, 2020 $ 46,578,543 112,989,141 (617,622) (155,611,155) 3,338,907
Shareholders' Equity (in shares) at Jun. 30, 2020 3,386,573,113        
Shareholders' Equity at Mar. 31, 2020 $ 40,085,648 109,596,064 (571,585) (147,294,500) 1,815,627
Shareholders' Equity (in shares) at Mar. 31, 2020 2,872,895,513        
Stock-based compensation   63,330     63,330
Issuance of share capital related to financing, net of issuance costs $ 5,953,175 2,941,966     8,895,142
Issuance of share capital related to financing, net of issuance costs (in shares) 471,666,700        
Issuance of share capital for entering into 2020 Purchase Agreement with Aspire Capital $ 523,778 376,222     900,000
Issuance of share capital for entering into 2020 Purchase Agreement with Aspire Capital (in shares) 40,760,900        
Issuance of share capital upon the exercise of warrants $ 15,941 11,559     27,500
Issuance of share capital upon the exercise of warrants (in shares) 1,250,000        
Comprehensive loss     (46,037) (8,316,655) (8,362,692)
Shareholders' Equity at Jun. 30, 2020 $ 46,578,543 $ 112,989,141 $ (617,622) $ (155,611,155) $ 3,338,907
Shareholders' Equity (in shares) at Jun. 30, 2020 3,386,573,113